développement d'approches de correction des myoblastes issus de patients atteints de la dystrophie facio-scapulo-humérale

développement d'approches de correction des myoblastes issus de patients atteints de la dystrophie facio-scapulo-humérale

La dystrophie Facio-Scapulo-Humérale est caractérisée par une faiblesse musculaire progressive et asymétrique. Elle affecte principalement les muscles faciaux, scapulaires et huméraux. L’association de plusieurs évènements épigénétiques à trois facteurs génétiques de la région subtélomérique du chro...

Full description

Bibliographic Details
Main Author:	Dib, Carla
Other Authors:	Université Paris-Saclay (ComUE)
Language:	fr
Published:	2018
Subjects:	Dfsh Thérapie cellulaire Ctcf CRISPR/Cas9 Chromosome 10 Stress oxydant Fshd Cell therapy Oxidative stress
Online Access:	http://www.theses.fr/2018SACLS224

Similar Items

Des mécanismes moléculaires pathologiques aux stratégies de correction génomique in vitro de la Dystrophie Facio-Scapulo-Humérale
by: Bou saada, Yara
Published: (2016)

CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer
by: Charles G Bailey, et al.
Published: (2018-11-01)

Selection of chromosomal DNA libraries using a multiplex CRISPR system
by: Owen W Ryan, et al.
Published: (2014-08-01)

CRISPR-PCDup: a novel approach for simultaneous segmental chromosomal duplication in Saccharomyces cerevisiae
by: Naim Hassan, et al.
Published: (2020-02-01)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
by: Romains Joubert, et al.
Published: (2021-12-01)

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
by: Charis L. Himeda, et al.
Published: (2021-03-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
by: Silvia Pomella, et al.
Published: (2020-03-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)

Gene editing and therapy – A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019-07-01)

SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
by: Reham Ajina, et al.
Published: (2019-05-01)

<i>ABL</i> Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
by: Shu-Huey Chen, et al.
Published: (2020-05-01)

Optimizing CRISPR Cas9 Genome Editing System: A Review
by: Meen Bahadur Budhthoki, et al.
Published: (2017-03-01)

CRISPR-Cas9: A Powerful Tool to Efficiently Engineer <i>Saccharomyces cerevisiae</i>
by: João Rainha, et al.
Published: (2021-12-01)

CRISPR genome editing and its medical applications
by: Mohammad-Reza Mahmoudian-sani, et al.
Published: (2018-03-01)

The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models
by: Ming SHAO, et al.
Published: (2016-07-01)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01)

Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering
by: Naoki Wada, et al.
Published: (2020-05-01)

Edição do gene TFAM pela engenharia CRISPR Cas9 em modelo bovino
by: Vanessa Cristina de Oliveira
Published: (2016)

Edição do gene TFAM pela engenharia CRISPR Cas9 em modelo bovino
by: Oliveira, Vanessa Cristina de
Published: (2016)

Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer
by: Tiruneh G/Medhin M, et al.
Published: (2021-05-01)

Etudes des translocations chromosomiques en utilisant les méthodes d'édition du génome : des mécanismes moléculaires à l’oncogenèse
by: Babin, Loélia
Published: (2019)

CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis
by: Evgenia Sarrou, et al.
Published: (2020-06-01)

Homology-dependent recombination of large synthetic pathways into E. coli genome via λ-Red and CRISPR/Cas9 dependent selection methodology
by: Buli Su, et al.
Published: (2020-05-01)

Rapid and Efficient CRISPR/Cas9-Based Mating-Type Switching of Saccharomyces cerevisiae
by: Ze-Xiong Xie, et al.
Published: (2018-01-01)

Rescue of an aggressive female sexual courtship in mice by CRISPR/Cas9 secondary mutation in vivo
by: Jozsef Zakany, et al.
Published: (2018-03-01)

Recombinant Adeno-Associated Viruses : process development and gene transfer application for muscular dystrophy
by: Dias Florencio Leite, Gabriella
Published: (2017)

The therapeutic potential of the CRISPR-Cas9 system for treating Duchenne muscular dystrophy
by: Rubin, David Sweeney
Published: (2016)

Ingénierie de génome de bactéries minimales par des outils CRISPR/Cas9
by: Tsarmpopoulos, Iason
Published: (2017)

Novel genome-editing tools to model and correct primary immunodeficiencies
by: Lisa M Ott De Bruin, et al.
Published: (2015-05-01)

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
by: Annalisa Lattanzi, et al.
Published: (2017-06-01)

CRISPR Interference–Potential Application in Retinal Disease
by: Caroline F. Peddle, et al.
Published: (2020-03-01)

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
by: Ewa Kruminis-Kaszkiel, et al.
Published: (2018-03-01)

New insights on CRISPR/Cas9-based therapy for breast Cancer
by: Hussein Sabit, et al.
Published: (2021-04-01)

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
by: Wei Sheng Siew, et al.
Published: (2021-08-01)

RNA Interference and CRISPR/Cas Gene Editing for Crop Improvement: Paradigm Shift towards Sustainable Agriculture
by: Meenakshi Rajput, et al.
Published: (2021-09-01)

RNA-dependent RNA targeting by CRISPR-Cas9
by: Steven C Strutt, et al.
Published: (2018-01-01)

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
by: Xiao-Hui Zhang, et al.
Published: (2015-01-01)

Macrophages derived from gene-edited pigs pose resistance to multiple isolates of Porcine Reproductive and Respiratory Syndrome virus
by: Bardot, Rachel Erin
Published: (2017)

In vivo genome editing thrives with diversified CRISPR technologies
by: Xun Ma, et al.
Published: (2018-03-01)

Cannot write session to /tmp/vufind_sessions/sess_orge24q1ar58ts76smvcnau3cc